CARM (CARISMA Therapeutics) Float Percentage Of Total Shares Outstanding: 86.71% (As of Jul. 04, 2026)


What is CARISMA Therapeutics Float Percentage Of Total Shares Outstanding?

CARISMA Therapeutics CARM +5.17% Float Percentage Of Total Shares Outstanding is 86.71% as of Jul. 04, 2026. The stock has 3 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, CARISMA Therapeutics's float shares is 36.29 Mil. CARISMA Therapeutics's total shares outstanding is 41.85 Mil. CARISMA Therapeutics's float percentage of total shares outstanding is 86.71%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, CARISMA Therapeutics's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, CARISMA Therapeutics's Institutional Ownership is 3.52%.

CARISMA Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

CARISMA Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=36.29/41.85
=86.71%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 86.71% mean?
CARISMA Therapeutics (CARM) has a Float Percentage Of Total Shares Outstanding of 86.71% as of Jul. 04, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on CARISMA Therapeutics and its competitors.
Is CARISMA Therapeutics' Float Percentage Of Total Shares Outstanding too high?
CARISMA Therapeutics' current Float Percentage Of Total Shares Outstanding is 86.71%.
How does CARISMA Therapeutics' Float Percentage Of Total Shares Outstanding compare to SCPX and CYTOF?
CARISMA Therapeutics' Float Percentage Of Total Shares Outstanding of 86.71% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on CARISMA Therapeutics and its competitors. CARISMA Therapeutics's current Float Percentage Of Total Shares Outstanding is 86.71%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CARISMA Therapeutics stock overvalued right now?
Based on GuruFocus' analysis, CARISMA Therapeutics (CARM) is currently considered Possible Value Trap. The stock's GF Value™ is $3.71, compared to a current price of $0.01 — trading 99.8% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 86.71%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For CARISMA Therapeutics (CARM), the current Float Percentage Of Total Shares Outstanding is 86.71% as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CARISMA Therapeutics Business Description

Address 3675 Market Street, Suite 200, Philadelphia, PA, USA, 19104
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.